Epstein-barr virus-associated hemophagocytic lymphohistiocytosis in adults characterized by high viral genome load within circulating natural killer Cells

Clinical Infectious Diseases

Volumn 51, Issue 1, 2010, Pages 66-69

  Fox, C P ^a   Shannon Lowe, C ^a   Gothard, P ^b   Kishore, B ^c   Neilson, J ^c   O'Connor, N ^d   Rowe, M ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c RUSSELLS HALL HOSPITAL   (United Kingdom)

^d ROYAL SHREWSBURY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; DEXAMETHASONE; ETOPOSIDE; GANCICLOVIR; IMMUNOGLOBULIN; METHYLPREDNISOLONE; RITUXIMAB;

ADULT; ARTICLE; CASE REPORT; EPSTEIN BARR VIRUS; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HUMAN; LABORATORY TEST; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT RESPONSE; VIRUS GENOME; VIRUS LOAD; BONE MARROW EXAMINATION; COMPLICATION; EPSTEIN BARR VIRUS INFECTION; GENETICS; HEMOPHAGOCYTIC SYNDROME; ISOLATION AND PURIFICATION; MIDDLE AGED; RETROSPECTIVE STUDY; VIROLOGY; YOUNG ADULT;

BONE MARROW EXAMINATION; EPSTEIN-BARR VIRUS INFECTIONS; GENOME, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; KILLER CELLS, NATURAL; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; VIRAL LOAD; YOUNG ADULT;

EID: 77953804800     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/653424     Document Type: Article

References (17)

1. Harabuchi Y, Yamanaka N, Kataura A, et al. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 1990;335(8682):128-130. (Pubitemid 20032725)
2. Kawaguchi H, Miyashita T, Herbst H, et al. Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome. J Clin Invest 1993;92(3):1444-1450. (Pubitemid 23273923)
3. Kasahara Y, Yachie A, Takei K, et al. Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Blood 2001;98(6):1882- 1888.
4. Henter JI, Home A, Arico M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007;48(2):124-131. (Pubitemid 44958267)
5. Ishii E, Ohga S, Imashuku S, et al. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol 2007;86(1):58-65. (Pubitemid 47204491)
6. Takahashi N, Chubachi A, Kume M, et al. A clinical analysis of 52 adult patients with hemophagocytic syndrome: the prognostic significance of the underlying diseases. Int J Hematol 2001;74(2):209-213. (Pubitemid 33760074)
7. Imashuku S, Kuriyama K, Sakai R, et al. Treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) in young adults: a report from the HLH study center. Med Pediatr Oncol 2003;41(2):103-109. (Pubitemid 36858327)
8. Elazary AS, Wolf DG, Amir G, et al. Severe Epstein-Barr virus-associated hemophagocytic syndrome in six adult patients. J Clin Virol 2007;40(2):156-159. (Pubitemid 47419424)
9. Quintanilla-Martinez L, Kumar S, Fend F, et al. Fulminant EBV(+) Tcell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologicsyndrome. Blood 2000;96(2):443-451. (Pubitemid 30463361)
10. Kasahara Y, Yachie A. Cell type specific infection of Epstein-Barr virus (EBV) in EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Crit Rev Oncol Hematol 2002;44(3):283-294. (Pubitemid 35435293)
11. Shannon-Lowe C, Adland E, Bell AI, Delecluse HJ, Rickinson AB, Rowe M. Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification. J Virol 2009;83(15):7749-7760.
12. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol 2001;22(11):633-640.
13. Beutel K, Gross-Wieltsch U, Wiesel T, Stadt UZ, Janka G, Wagner HJ. Infection of T lymphocytes in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children of non-Asian origin. Pediatr Blood Cancer 2009;53(2):184-190.
14. Yoshioka M, Kikuta H, Ishiguro N, Endo R, Kobayashi K. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome. J Med Virol 2003;70(3):410-419. (Pubitemid 36638055)
15. Iwakiri D, Zhou L, Samanta M, et al. Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-intected cells and activates signaling from toll-like receptor 3. J Exp Med 2009;206(10):2091-2099.
16. Karras A, Thervet E, Legendre C. Hemophagocytic syndrome in renal transplant recipients: report of 17 cases and review of literature. Transplantation 2004;77(2):238-243. (Pubitemid 38155753)
17. Menard F, Besson C, Rince P, et al. Hodgkin lymphoma-associated hemophagocytic syndrome: a disorder strongly correlated with EpsteinBarr virus. Clin Infect Dis 2008;47(4):531-534.